Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders worldwide. It is associated with clinical states such as obesity, insulin resistance, and type 2 diabetes, and covers a wide range of liver changes, ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), liver cirrhosis, and hepatocellular car...
Alternative Titles
Full title
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5409726
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5409726
Other Identifiers
ISSN
2072-6643
E-ISSN
2072-6643
DOI
10.3390/nu9040387
